<DOC>
	<DOCNO>NCT01515202</DOCNO>
	<brief_summary>The purpose clinical study ass safety tolerability multiple oral dos BMS-823778 healthy Japanese subject Japanese patient Type 2 Diabetes Mellitus .</brief_summary>
	<brief_title>Japanese Phase 1 Multiple Ascending Dose Study</brief_title>
	<detailed_description>MAD study - Multiple Ascending Dose study</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Japanese patient Type 2 Diabetes Mellitus ( T2DM ) [ Fasting glucose &lt; 240 mg/dL , Hemoglobin A1c ( HbA1c ) : 6.5 % 10.0 % National Glycohemoglobin Standardization Program ( NGSP ) ] treatmentnaive manage diet and/or exercise , age : 20 65 year Patient take medication T2DM Symptoms poorly control diabetes would preclude participation placebocontrolled trial Insulin therapy within one year screening</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>